The Reinstatement Model and Relapse Prevention: a Clinical Perspective

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2003 May 2

PMID 12721778

Citations 82

Authors

David H Epstein

Kenzie L Preston

Affiliations

Soon will be listed here.

Abstract

Objectives: This commentary assesses the degree to which the reinstatement model is homologous to the human experience of relapse.

Results: A review of the literature suggests that the relationship is less clear than is often assumed, largely due to a lack of prospective data on the precipitants and process of relapse (especially relapse to heroin or cocaine abuse). However, reinstatement does not need to resemble relapse to have immediate clinical value; predictive validity as a medication screen would be sufficient. Whether the model has predictive validity is unknown, because, to date, very few clinical trials have tested medications that are effective in the reinstatement model, and even fewer have used designs comparable to those of reinstatement experiments. A clinical trial comparable to a reinstatement experiment would enroll participants who are already abstinent, and its main outcome measure would be propensity to undergo a specific type of relapse (e.g., relapse induced by stress or cues).

Conclusions: Until clinical and preclinical work are more comparable, criticisms of the reinstatement model's presumed shortcomings are premature.

Citing Articles

Relapse after intermittent access to cocaine: Discriminative cues more effectively trigger drug seeking than do conditioned cues.

Ndiaye N, Shamleh S, Casale D, Castaneda-Ouellet S, Laplante I, Robinson M Psychopharmacology (Berl). 2024; 241(10):2015-2032.

PMID: 38767684 DOI: 10.1007/s00213-024-06614-9.

Examining a punishment-related brain circuit with miniature fluorescence microscopes and deep learning.

Broomer M, Beacher N, Wang M, Lin D Addict Neurosci. 2024; 11.

PMID: 38680653 PMC: 11044849. DOI: 10.1016/j.addicn.2024.100154.

Relapse after electric barrier-induced voluntary abstinence: A review.

Negishi K, Fredriksson I, Bossert J, Zangen A, Shaham Y Curr Opin Neurobiol. 2024; 86:102856.

PMID: 38508102 PMC: 11162942. DOI: 10.1016/j.conb.2024.102856.

Role of Piriform Cortex and Its Afferent Projections in Relapse to Fentanyl Seeking after Food Choice-Induced Voluntary Abstinence.

Claypool S, Reiner D, Behdin S, Orihuel J, Batista A, Caldwell K J Neurosci. 2023; 43(14):2597-2614.

PMID: 36898838 PMC: 10082459. DOI: 10.1523/JNEUROSCI.0034-23.2023.

Role of ventral subiculum neuronal ensembles in incubation of oxycodone craving after electric barrier-induced voluntary abstinence.

Fredriksson I, Tsai P, Shekara A, Duan Y, Applebey S, Minier-Toribio A Sci Adv. 2023; 9(2):eadd8687.

PMID: 36630511 PMC: 9833671. DOI: 10.1126/sciadv.add8687.

References

Baker D, Fuchs R, Neisewander J . Influence of individual differences and chronic fluoxetine treatment on cocaine-seeking behavior in rats. Psychopharmacology (Berl). 2001; 155(1):18-26. DOI: 10.1007/s002130000676. View

Haney M, Ward A, Foltin R, FISCHMAN M . Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berl). 2001; 155(4):330-7. DOI: 10.1007/s002130100725. View

Grimm J, Hope B, Wise R, Shaham Y . Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature. 2001; 412(6843):141-2. PMC: 2889613. DOI: 10.1038/35084134. View

Lando H, Valanis B, Lichtenstein E, Curry S, McBride C, Pirie P . Promoting smoking abstinence in pregnant and postpartum patients: a comparison of 2 approaches. Am J Manag Care. 2001; 7(7):685-93. View

Wiesbeck G, Weijers H, Lesch O, Glaser T, Toennes P, Boening J . Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study. Alcohol Alcohol. 2001; 36(4):329-34. DOI: 10.1093/alcalc/36.4.329. View

Highfield D, Yap J, Grimm J, Shalev U, Shaham Y . Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin-cocaine mixture (speedball) seeking in rats. Neuropsychopharmacology. 2001; 25(3):320-31. DOI: 10.1016/S0893-133X(01)00227-5. View

McMahon R . Personality, stress, and social support in cocaine relapse prediction. J Subst Abuse Treat. 2001; 21(2):77-87. DOI: 10.1016/s0740-5472(01)00187-8. View

Hays J, Hurt R, Rigotti N, Niaura R, Gonzales D, Durcan M . Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Ann Intern Med. 2001; 135(6):423-33. DOI: 10.7326/0003-4819-135-6-200109180-00011. View

de Vries T, Shaham Y, Homberg J, CROMBAG H, Schuurman K, Dieben J . A cannabinoid mechanism in relapse to cocaine seeking. Nat Med. 2001; 7(10):1151-4. DOI: 10.1038/nm1001-1151. View

10.

Streeton C, Whelan G . Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol Alcohol. 2001; 36(6):544-52. DOI: 10.1093/alcalc/36.6.544. View

11.

Schmidt L, Kuhn S, Smolka M, Schmidt K, Rommelspacher H . Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence. Prog Neuropsychopharmacol Biol Psychiatry. 2002; 26(2):209-17. DOI: 10.1016/s0278-5846(01)00214-7. View

12.

Brady K, Myrick H, Henderson S, Coffey S . The use of divalproex in alcohol relapse prevention: a pilot study. Drug Alcohol Depend. 2002; 67(3):323-30. DOI: 10.1016/s0376-8716(02)00105-9. View

13.

Longo L . Olanzapine for cocaine craving and relapse prevention in 2 patients. J Clin Psychiatry. 2002; 63(7):595-6. DOI: 10.4088/jcp.v63n0710c. View

14.

Le A, Shaham Y . Neurobiology of relapse to alcohol in rats. Pharmacol Ther. 2002; 94(1-2):137-56. DOI: 10.1016/s0163-7258(02)00200-0. View

15.

Liu X, Weiss F . Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci. 2002; 22(18):7856-61. PMC: 6758095. View

16.

Ciccocioppo R, Martin-Fardon R, Weiss F . Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology. 2002; 27(3):391-9. DOI: 10.1016/S0893-133X(02)00302-0. View

17.

Crombag H, Grimm J, Shaham Y . Effect of dopamine receptor antagonists on renewal of cocaine seeking by reexposure to drug-associated contextual cues. Neuropsychopharmacology. 2002; 27(6):1006-15. DOI: 10.1016/S0893-133X(02)00356-1. View

18.

Shaham Y, Shalev U, Lu L, de Wit H, Stewart J . The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl). 2002; 168(1-2):3-20. DOI: 10.1007/s00213-002-1224-x. View

19.

Wise R, Murray A, Bozarth M . Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology (Berl). 1990; 100(3):355-60. DOI: 10.1007/BF02244606. View

20.

McElroy S, Weiss R, MENDELSON J, Teoh S, McAfee B, Mello N . Desipramine treatment for relapse prevention in cocaine dependence. NIDA Res Monogr. 1989; 95:57-63. View